Interpreting segmental glomerular sclerosis

Current Diagnostic Pathology

Volumn 10, Issue 1, 2004, Pages 1-10

  Rossini, M ^a   Fogo, A B ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Focal segmental glomerulosclerosis; FSGS; Nephrotic syndrome; Secondary FSGS

Indexed keywords

CONFERENCE PAPER; CYTODIAGNOSIS; DISEASE CLASSIFICATION; ELECTRON MICROSCOPY; GLOMERULOSCLEROSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; MICROSCOPY; MORPHOLOGICAL TRAIT; PATHOGENESIS; PROGNOSIS;

EID: 1642512412     PISSN: 09686053     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cdip.2003.09.001     Document Type: Conference Paper

References (37)

1. Rennke H, Klein PS. Pathogenesis and significance of non-primary focal and segmental glomerulosclerosis. Am J Kidney Dis 1989;13:443-55.
2. Schwartz MM, Korbet SM, Rydell J, et al. Primary focal segmental glomerular sclerosis in adults: prognostic value of histologic variants. Am J Kidney Dis 1995;25:845-52.
3. D'Agati V. The many masks of focal segmental glomerulosclerosis. Kidney Int 1994;46:1223-41.
4. Howie AJ, Lee SJ, Green NJ, et al. Different clinicopathological types of segmental sclerosing glomerular lesions in adults. Nephrol Dial Transplant 1993;8:590-9.
5. Cameron JS. The enigma of focal segmental glomerulosclerosis. Kidney Int 1996;50:S119-31.
6. Fogo A, Ichikawa I. Focal segmental glomerulosclerosis-a view and review. Pediatr Nephrol 1996;10:374-91.
7. Corwin HL, Schwartz MM, Lewis EJ. The importance of sample size in the interpretation of the renal biopsy. Am J Nephrol 1988;8:85-9.
8. Rich AR. A hitherto undescribed vulnerability of the juxtamedullary glomeruli in lipoid nephrosis. Bull Johns Hopkins Hosp 1957;100:173-86.
9. Fogo A, Glick AD, Horn SL, Horn RG. Is focal segmental glomerulosclerosis really focal? Distribution of lesions in adults and children. Kidney Int 1995;47:1690-6.
10. Fogo A, Hawkins EP, Berry PL, et al. Glomerular hypertrophy in minimal change disease predicts subsequent progression to focal glomerular sclerosis. Kidney Int 1990;8:115-23.
11. Fogo AB. Glomerular hypertension, abnormal glomerular growth and progression of renal disease. Kidney Int 2000;57(suppl 75):S15-21.
12. Cohen AH, Border WA, Glassock RJ. Nephrotic syndrome with glomerular mesangial IgM deposits. Lab Invest 1978;38:610-9.
13. Tejani A, Nicastri AD. Mesangial IgM nephropathy. Nephron 1983;35:1-5.
14. Saha H, Mustonen J, Pasternack A, Helin H. Clinical follow up of 54 patients with IgM nephropathy. Am J Nephrol 1989; 9:124-8.
15. Border WA. Distinguishing minimal-change disease from mesangial disorders. Kidney Int 1988;34:419-34.
16. Southwest Pediatric Nephrology Study Group. A report: focal segmental glomerulosclerosis in children with idiopathic nephrotic syndrome. Kidney Int 1985;27:442-9.
17. Devarajan P, Spitzer A. Towards a biological characterization of focal segmental glomerulosclerosis. Am J Kidney Dis 2002;39:625-36.
18. D'agati V. Pathologic classification of focal segmental glomerulosclerosis. Semin Nephrol 2003;23:117-34.
19. Detwiler RK, Falk RJ, Hogan SL, Jennette JC. Collapsing glomerulopathy: a clinically and pathologically distinct variant of focal segmental glomerulosclerosis. Kidney Int 1994;45:1416-24.
20. D'Agati V, Suh J-I, Carbone L, Appel GB. Pathology of HIV-associated nephropathy: a detailed morphologic and comparative study. Kidney Int 1989;35:1358-70.
21. Moudgil A, Nast CC, Bagga A, et al. Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy. Kidney Int 2001;59:2126-33.
22. Markowitz GS, Appel GB, Fine PL, et al. Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate. J Am Soc Nephrol 2001;12:1164-72.
23. Nadasdy T, Allen C, Zand MS. Zonal distribution of glomerular collapse in renal allografts: possible role of vascular changes. Hum Pathol 2002;33:437-41.
24. Meehan SM, Pascual M, Williams WW, et al. De novo collapsing glomerulopathy in renal allografts. Transplantation 1998;65:1192-7.
25. Stokes MB, Davis CL, Alpers CE. Collapsing glomerulopathy in renal allografts: a morphological pattern with diverse clinicopathologic associations. Am J Kidney Dis 1999; 33:658-66.
26. Pollak MR. The genetic basis of FSGS and steroid-resistant nephrosis. Semin Nephrol 2003;23:141-6.
27. Kim JM, Wu H, Green G, et al. CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility. Science 2003;300:1298-300.
28. Hotta O, Inoue CN, Miyabayashi S, Furuta T, Takeuchi A, Taguma Y. Clinical and pathologic features of focal segmental glomerulosclerosis with mitochondrial tRNALeu(UUR) gene mutation. Kidney Int 2001;59: 1236-43.
29. Savin VJ, Sharma R, Sharma M, et al. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 1996;334:878-83.
30. Li RM, Branton MH, Tanawattanacharoen S, Falk RA, Jennette JC, Kopp JB. Molecular identification of SV40 infection in human subjects and possible association with kidney disease. J Am Soc Nephrol 2002;13: 2320-30.
31. Barisoni L, Bruggeman LA, Mundel P, D'Agati VD, Klotman PE. HIV-1 induces renal epithelial dedifferentiation in a transgenic model of HIV-associated nephropathy. Kidney Int 2000;58:173-81.
32. Jennette JC, Hipp CG. C1q nephropathy: a distinct pathologic entity usually causing nephrotic syndrome. Am J Kidney Dis 1985;6:103-10.
33. Jones E, Magil A. Nonsystemic mesangiopathic glomerulonephritis with 'full house' immunofluorescence. Pathologic and clinical observations in five patients. Am J Clin Pathol 1982;78:29-34.
34. Iskandar SS, Browning MC, Lorentz WB. C1q nephropathy: a pediatric clinicopathologic study. Am J Kidney Dis 1991;18:459-65.
35. Marcantoni C, Ma L-J, Federspiel C, Fogo AB. Hypertensive nephrosclerosis in African Americans versus Caucasians. Kidney Int 2002;62:172-80.
36. Cohen AH, Nast CC. HIV-associated nephropathy: a unique combined glomerular, tubular, and interstitial lesion. Mod Pathol 1988;1:87-97.
37. Kimmel PL. The nephropathies of HIV infection: pathogenesis and treatment. Curr Opin Nephrol Hypertens 2000; 9:117-22.